Related Experiment Video
Updated: Jul 1, 2026
06:24
Mouse Models of Periventricular Leukomalacia
Published on: May 18, 2010
Lupus myelopathy in a child.
José Pedro Vieira1, Oscar Ortet, Deolinda Barata
1Neurology Department, Hospital de Dona Estefânia, Lisbon, Portugal.
Pediatric Neurology
|November 19, 2002
Summary
This case study highlights a rare instance of lupus myelopathy in a young child, presenting with neurological symptoms and kidney issues. Early diagnosis and treatment are crucial for managing this severe complication of systemic lupus erythematosus.
Area of Science:
- Pediatric Neurology
- Rheumatology
- Immunology
Background:
- Systemic lupus erythematosus (SLE) is a chronic autoimmune disease that can affect multiple organ systems.
- Neurological complications, such as lupus myelopathy, are serious manifestations of SLE, particularly in pediatric cases.
- Transverse myelopathy involves inflammation across the spinal cord, leading to neurological deficits.
Observation:
- A 5-year-old female presented with prolonged fever, anorexia, weight loss, and a transient skin rash.
- She subsequently developed acute transverse myelopathy with partial motor and sensory recovery.
- Laboratory findings included positive antinuclear and anti-double-stranded DNA antibodies, but negative antiphospholipid antibodies.
- Massive proteinuria indicated subsequent lupus nephritis, requiring treatment with steroids and cyclophosphamide.
Findings:
- The patient exhibited a rare presentation of lupus myelopathy at a very young age.
- Magnetic resonance imaging (MRI) findings, clinical presentation, and laboratory results were consistent with lupus myelopathy.
- The co-occurrence of myelopathy and lupus nephritis underscores the systemic nature of the disease.
Implications:
- This case emphasizes the importance of considering lupus myelopathy in the differential diagnosis of acute myelopathy in children, even in the absence of antiphospholipid antibodies.
- Prompt recognition and management of SLE-related neurological complications are vital for improving patient outcomes.
- Further research into the pathogenesis and treatment of pediatric lupus myelopathy is warranted.
Related Concept Videos
01:17Poliomyelitis
Poliomyelitis is caused by poliovirus, a small, non-enveloped, positive-sense RNA virus of the Picornaviridae family and Enterovirus genus. Transmission occurs primarily via the fecal-oral route, often through ingestion of contaminated water or food. The virus initially replicates in the oropharynx and intestinal mucosa, particularly in lymphoid tissues such as the tonsils, Peyer’s patches, and regional lymph nodes. Primary viremia follows, allowing dissemination throughout the body.In most...
01:19Multiple Sclerosis l: Introduction
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
01:25Secondary Spinal Cord Injury llI: Pathophysiology
Early Ischemia and Ionic ImbalanceWithin minutes of spinal cord injury, a secondary cascade begins, progressing over hours to weeks. Vascular damage reduces blood flow, causing ischemia and mitochondrial dysfunction. ATP depletion leads to ion pump failure, membrane depolarization, sodium influx, potassium efflux, and water accumulation, resulting in cellular swelling. Increased intracellular calcium further disrupts mitochondria and accelerates cellular injury.Excitotoxicity and Neuronal...